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To address conflicting results about the stability of vari-
able number tandem repeat (VNTR) loci and their value in 
prospective molecular epidemiology of Mycobacterium tuber-
culosis, we conducted a large prospective population-based 
analysis of all M. tuberculosis strains in a metropolitan set-
ting. Optimal and reproducible conditions for reliable PCR 
and fragment analysis, comprising enzymes, denaturing con-
ditions, and capillary temperature, were identified for a panel 
of hypervariable loci, including 3232, 2163a, 1982, and 4052. 
A total of 2,261 individual M. tuberculosis isolates and 265 
sets of serial isolates were analyzed by using a standardized 
15-loci VNTR panel, then an optimized hypervariable loci 
panel. The discriminative ability of loci varied substantially; 
locus VNTR 3232 varied the most, with 19 allelic variants 
and Hunter-Gaston index value of 0.909 . Hypervariable loci 
should be included in standardized panels because they can 
provide consistent comparable results at multiple settings, 
provided the proposed conditions are adhered to.
Globally, tuberculosis (TB) accounts for almost 2 mil-lion deaths each year (1). Although TB notification 
rates in the United Kingdom (13.8/100,000 in 2007) re-
main low, rates differ substantially by region: London 
(43.2/100,000) accounts for ≈40% of all TB cases regis-
tered in the United Kingdom, and ≈75% of TB patients in 
London were born abroad (2). Rates of drug resistance also 
are higher in London than in the rest of the United King-
dom: 8.6% of isolates are isoniazid resistant, and 1.2% are 
multidrug resistant (UK Health Protection Agency; www.
hpa.org.uk).
In settings where incidence of TB is low or moderate, 
molecular genotyping is used to investigate suspected TB 
outbreaks, laboratory cross-contamination, and reactivation 
and (at a population level) to identify clustered cases that 
are not apparently linked; for the latter purpose, the highest 
possible level of discrimination is required (3). For these 
purposes, insertion sequence (IS) 6110 restriction fragment 
length polymorphism (RFLP) analysis—often supplement-
ed with spoligotyping and, more recently, with variable 
number tandem repeat (VNTR) typing—is used routinely.
The highest levels of epidemiologic discrimination 
of strains of the Mycobacterium tuberculosis complex 
(MTBC) can be achieved by using multilocus VNTR typ-
ing, but these results depend on the number and loci used, 
particularly for homogenous strain groups such as the 
Beijing family (3–5). This approach overcomes technical 
difficulties associated with IS6110-RFLP and is amenable 
to automation that results in a high throughput (6–10). 
A standardized panel of 15 + 9 VNTR loci (24 loci) has 
been proposed (7,11), but it is unclear whether sufficient 
discrimination would be seen when the panel is used in 
populations with a substantial prevalence of homogenous 
MTBC families (4,5,12). In addition, the discriminative 
power of VNTR loci may vary markedly among genetic 
families (7,13). Recent studies evaluating the discriminative 
power of VNTR typing have produced conflicting results 
that were generated by using convenience samples (small 
populations with low diversity or populations confined to a 
single geographic setting). These studies highlighted a need 
for larger population-based studies to identify discrimina-
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tive VNTR loci and ascertain their applicability for various 
genetic groups.
Concerns about the stability and reproducibility of 
particularly useful hypervariable loci, such as 3232, 2163a, 
3336, and 1982 (3–5,14), have been raised (7,15). As a 
result, they have been excluded from the proposed inter-
national panels for VNTR typing. For these reasons, we 
conducted a study to examine the stability of hypervariable 
loci and the parameters associated with reproducibility, to 
select loci suitable for prospective molecular epidemiologic 
studies, and to evaluate the discriminatory power of these 
loci at a population level in a metropolitan setting.
Materials and Methods
Bacterial Isolates
A total of 2,261 individual MTBC isolates (1 per pa-
tient) were included in this prospectively designed popula-
tion study. These isolates represented 95.7% of the bacteri-
ologically confirmed TB cases reported from the 30 London 
hospitals in the 12 months from April 2005 through March 
2006. These isolates had been characterized by using spoli-
gotyping, and all but 4 were assigned to 1 of 36 spoligotype 
families (16,17). Multiple isolates were available from 265 
patients (11.7%), resulting in serial isolate sets of 2–6 iso-
lates, which had been sampled at intervals of 3 days to 11 
months (N = 632).
Multilocus VNTR Analysis
All extracts were typed by using 15 mycobacterial in-
terspersed repetitive unit (MIRU)-VNTR loci as previously 
described (3). Isolates clustered when the 15 MIRU- Hunter-
Gaston index value VNTR profiles we used were reanalyzed 
with an additional panel of VNTR loci 2163b, 2347, 3232, 
2163a, 1982, 3336, and 4052 as previously described (3,5) 
after optimization of factors affecting reproducibility (see 
Hypervariable Loci Optimization). Variability or discrimi-
nation at a locus was assessed by using the Hunter-Gaston 
Discriminative Index (HGDI) (18). Loci with HGDI values 
<0.3, 0.3–0.6, and >0.6 were considered poorly, moderate-
ly, and highly discriminative, respectively (19).
Hypervariable Loci Optimization
We selected 16 previously characterized MTBC iso-
lates to cover the complete range of repeat sizes at control 
loci MIRU 26 and exact tandem repeat (ETR)–B and experi-
mental hypervariable loci VNTRs 1982 and 3232 (except 0 
repeats for the locus 3232). For each of the 16 extracts, four 
10-µL PCRs were conducted for each of the primer mixes 
in duplicate. Of these 4 reactions, the first was performed 
as described previously with BIOTAQ polymerase (Bio-
line, London, UK) (any enzyme in the given context means 
enzyme in conjunction with the buffer recommended and 
supplied by a manufacturer). Three other sets of PCRs were 
conducted under different amplification conditions (1).
Method 1
Diamond DNA polymerase (Bioline) was used (9). 
The PCR amplification cycle was 3 min at 95°C, followed 
by 35 cycles of 30 s at 95°C, 30 s at 60°C, and 2 min at 
72°C, and 1 final cycle of 5 min at 72°C (2).
Method 2
HotStartTaq DNA polymerase (QIAGEN, Hilden Ger-
many) was used. Each 10-µL reaction contained 1× PCR 
buffer (QIAGEN), 0.25 U/µL of the relevant polymerase, 
0.2 µmol/L dNTPs, 0.125 µmol/L of relevant primer, and 
5% dimethylsulfoxide. The DNA amplification cycle was 
15 min at 95°C, followed by 35 cycles of 30 s at 94°C, 30 
s at 60°C, and 1 min at 72°C, and a final cycle of 10 min 
at 72°C (3). 
Method 3
HotStartTaq Plus DNA polymerase (QIAGEN) was 
used. The PCR mixture was the same as in method 2, and 
the amplification cycle was the same, except that the initial 
95°C activation time was reduced to 5 min.
We manually calculated the number of repeats within 
each PCR product by resolving 4 µLof each product on a 
1.2% (wt/vol) agarose gel (Agarose LE Analytical grade; 
Promega, Southampton, UK) against a 2,000-bp Hyper-
Ladder II standard (Bioline). The number of repeats at each 
locus also was calculated by sizing in a denaturing capil-
lary electrophoresis system using a CEQ 8000 instrument 
with a DNA Size Standard 600 (Beckman Coulter, High 
Wycombe, UK) and MapMarker D1 labeled 640–1000 
(BioVentures, Inc., Murfreesboro, TN, USA) because frag-
ments were expected to be >600 bp. Three parameter sets 
(Table 1) were used to analyze all fragments. The different 
parameters examined were capillary temperature (60°C for 
methods 1 and 2 and 50°C for method 3, respectively), de-
naturation time (120 s for method 1 and 180 s for methods 2 
and 3, respectively) and separation time (60 min for meth-
ods 1 and 2 and 70 min for method 3, respectively). Frag-
ment data traces were automatically analyzed by using the 
scheme shown in Table 1. For locus 3232, we accounted 
for offset values (i.e., difference among actual sizes of PCR 
fragments and apparent sizes indicated by electrophoresis) 
when calculating number of repeats in Table 1.
Assessing Stability and Reproducibility of VNTR Loci
All isolates were grouped into 265 sets of serial isolates 
(2–6 isolates each) and typed at all 22 loci. Primer sequenc-
es for all loci were as described previously (3,9,20,21). PCR 
was set up by using BIOTAQ polymerase for amplifying 
12 MIRU and 3 ETR loci and Diamond polymerase for the 
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additional 7 VNTR loci. Capillary electrophoresis was per-
formed by using the parameters described in method 1.
Results
Optimization of Hypervariable Loci
We evaluated factors that potentially affect the repro-
ducibility of hypervariable VNTR loci by using various 
PCR and capillary and manual electrophoresis separation 
conditions as described in the Materials and Methods. The 
ability to correctly amplify different VNTR loci depended 
on the enzyme used (Table 2); all polymerases efficiently 
amplified MIRU 26 and ETR-B, as indicated by the pres-
ence of PCR fragments on agarose gels and capillary elec-
trophoresis peaks. However, locus VNTR 3232 was ampli-
fied effectively only with Bioline Diamond (15/16 strains, 
93.8%). Although all polymerases except Bioline BIOTAQ 
were able to amplify DNA at locus VNTR 1982, longer 
fragments were amplified more efficiently by QIAGEN 
and Bioline Diamond polymerases. Therefore, Diamond 
polymerase was selected for the amplification of additional 
VNTR loci.
We assessed 3 methods for capillary electrophoresis. 
For each locus, apparent fragment sizes were plotted against 
expected fragment sizes for each method (Figure 1).
MIRU 26 fragments sizes were as expected for all al-
lelic variants (except for the variant with 2 repeats) when 
BIOTAQ and Diamond polymerases were used, but sizes 
were larger than expected with QIAGEN polymerases. The 
smaller ETR-B fragments with 1 and 2 repeats all gave ex-
pected sizes with methods 1 and 2 but were less than ex-
pected with method 3 (where the capillary temperature was 
decreased). These results did not affect overall interpreta-
tion. For the higher number of repeats (4–6 repeats), all 
polymerases generated fragments that, when analyzed by 
using method 3, gave apparent sizes lower than expected. 
In some cases, this result affected the interpretation. The 
apparent sizes of VNTR 1982 fragments were all similar 
to the expected values independent of the polymerase used 
and the method used for capillary electrophoresis.
Serial Isolates
Amplification was performed by using BIOTAQ 
polymerase for 12 MIRU and 3 ETR loci and Diamond 
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Table 1. Expected molecular weights of Mycobacterium 
tuberculosis of fragments at each locus, with different numbers  
of copies, London, UK, 2005–2006* 
Length of expected fragments for each locus, bp 
No. repeats MIRU 26 ETR-B VNTR 1982 VNTR 3232†
0 244 121 178
1 295 174 256 242
2 344 227 334 286
3 393 280 412 330
4 442 333 490 372
5 491 386 568 415
6 540 439 646 458
7 589 492 727 501
8 638 545 802 546
9 687 598 880 587
10 736 651 958 630
11 785 1,038 673
12 834 1,116 716
13 883 1,194 759
14 932 802
15 845
16 888
17 931
18 974
19 1,017
20 1,060
*MIRU, mycobacterial interspersed repetitive unit; ETR, exact tandem 
repeat; VNTR, variable number tandem repeats. 
†No isolates had 0 repeats in locus 3232 in our population. 
Table 2. Number of DNA extracts (from n = 16) for which peaks were detected by different conditions for capillary electrophoresis of
Mycobaterium tuberculosis after amplifying the loci with different polymerases, London, UK, 2005–2006* 
Bioline polymerases‡ QIAGEN polymerases‡ 
Locus Method† BIOTAQ Diamond HotStartTaq HotStartTaq Plus 
MIRU 26 1 16 16 16 (1) 16 (1) 
2 15 16 16 (1) 16 (1) 
3 16 16 16 16
ETR-B 1 16 16 16 (1) 16 (1) 
2 15 16 16 (1) 16 (1) 
3 16 16 16 (2) 16 (2) 
VNTR 1982 1 8 13 14 14
2 9 13 12 14
3 6 11 12 14
VNTR 3232 1 11 15 13 14
2 10 15 14 14
3 11 (3) 15 (7) 13 (6) 13 (4) 
*MIRU, mycobacterial interspersed repetitive unit; ETR, exact tandem repeat; VNTR, variable number tandem repeats. 
†Refer to Table 1. 
‡Numbers in parentheses represent number of extracts whose calculated number of repeats were higher and lower than the expected value on the basis 
of that produced by the standard procedure (method 1). 
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polymerase for 7 VNTR loci with the optimized param-
eters in method 1. Analysis was blinded. No disagreements 
occurred in the interpretation of VNTR repeat numbers 
among isolates in a set. In a proportion of isolates (N = 
124), genotyping results were validated by using both cap-
illary electrophoresis and manual electrophoresis for PCR 
fragment separation, and again, no discrepancies were 
found between VNTR loci copy numbers in strains isolated 
from the same patient at different time points (Figure 2).
Population Genotyping in Metropolitan Setting  
with 2 Panels of VNTR Loci
A total of 2,261 MTBC isolates circulating in London 
with known spoligotypes were genotyped by using a defined 
set of 15 loci (12 MIRU and 3 ETR); all known spoligotyp-
ing families were represented in the test population (online 
Technical Appendix, available from www.cdc.gov/EID/
content/15/10/1609-Techapp.pdf). Complete 15-loci profiles 
were obtained for 2,046 strains (90.5% of all strains). Data 
for the remaining profiles were incomplete for >1 locus. 
Overall PCR failure rate was 1.6%, with the highest number 
of failures (n = 72) at locus ETR-A and the lowest number 
of failures (n = 4) at locus ETR-C. When PCR failed, DNA 
was reextracted from original cultures, and genotyping was 
attempted again. If the second attempt was unsuccessful, the 
results for the locus were marked as missing.
Genotyping of MTBC isolates by using 15 MIRU-ETR 
loci yielded 1,036 unique profiles and 235 clusters contain-
ing 2–53 isolates (Table 3). Clustered profiles were shared 
by 1,225 isolates, giving a clustering rate of 54.2%.
Subsequently, 1,196 (97.6%) of 1,225 isolates (15 
MIRU-ETR clustered isolates) were subjected to second-
ary typing by using VNTR loci 2163b, 2347, 3232, 2163a, 
1982, 3336, and 4052. Resolution improved because strains 
that had been clustered initially were subdivided into new 
groups: 1,730 isolates now had unique genotyping patterns, 
and the remaining 502 isolates were grouped into 158 clus-
ters, giving a new, substantially lower, clustering rate of 
22.2% (Table 3).
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Figure 1. Effect of various enzymes and separation conditions on amplification and detectable molecular weights of PCR fragments for 
4 variable number tandem repeat (VNTR) loci. A) Mycobacterial interspersed repetitive unit locus 26; B) locus exact tandem repeat; C) 
locus 1982; D) locus 3232.
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Variability and Discriminative Power of VNTR Loci
The discriminative ability of VNTR loci varied mark-
edly among the 22 VNTR loci and among spoligotyping 
families (online Technical Appendix) with locus VNTR 
3232 showing the greatest variation (HGDI = 0.909 and 19 
allelic variants) and loci MIRU 2 and 20, the least (HGDI = 
0.134 and 0.196; number of allelic variants 4 and 3, respec-
tively). Twelve loci each had >10 allelic variants. MIRU 
4 showed moderate discriminative power, and MIRU 
10, MIRU 16, MIRU 23, MIRU 26, MIRU 40, ETR-A, 
ETR-C, and VNTR 2163B, 2163A, 1982, 3232, 3336, and 
4052 showed high discriminative power with HGDI val-
ues varying from 0.524 to 0.909. None of the 22 loci were 
monomorphic in the current study. With the exception of 
VNTR 2347, all loci included in the additional VNTR pan-
el displayed higher variability than the primary panel of 15 
MIRU-ETR loci used for UK national typing, which indi-
cates their potential for increasing the power of prospective 
molecular genotyping.
The discriminative power of VNTR loci also varied 
among spoligotype families. The mean 15 MIRU-ETR 
HGDI value for the Beijing family was low (0.163), which 
indicates that this family is relatively homogeneous, even 
within the diverse London population settings. Notably, 
mean 15 MIRU-ETR HGDI values for genetic families 
within the Euro-American lineage (T, Haarlem, S, X, 
Latin American–Mediterranean) were generally higher 
(0.307–0.378) than those for Beijing and Central Asian 
(CAS) (0.235). Within spoligotype families, the additional 
7 VNTR increased variability in all cases, except for M. 
bovis. The highest HGDI were seen in the Latin Ameri-
can–Mediterranean family with locus 2163B; in Beijing, 
Haarlem, and M. africanum with VNTR 3232; in East Af-
rican–Indian with VNTR 2163A; in X with VNTR 1982; 
in T with VNTR 3336; and in CAS with VNTR 4052. 
Within the East African–Indian family, the hypervariable 
loci VNTR 3232 varied little, with 93.7% isolates having 
a single copy. A small proportion of strains (Table 4) ana-
lyzed by using more discriminative loci, including VNTR 
3232, 1982, 2163A, and 3336, generated PCR products that 
were too large for automated analysis but were resolved 
manually.
Discussion
Polymorphisms in rapidly evolving repetitive se-
quences, such as minisatellite VNTR, are a valuable tool 
for prospective epidemiologic analyses and provide a high 
degree of discrimination in situations in which few a priori 
epidemiologic data are available. In this population-based 
study, we genotyped 2,261 individual MTBC isolates ob-
tained from patients residing in London by using 22 VN-
TR-MIRU loci.
Conflicting views on the use of hypervariable loci for 
typing have been reported, even when loci such as VNTR 
3232 have been shown to have high discriminatory pow-
er (3,5,14). Some studies have demonstrated difficulty in 
amplification of multiple alleles, absence of PCR ampli-
fication products, varying data interpretation, and lack of 
reproducibility among laboratories (7). Similar problems 
were found with another potentially valuable hypervariable 
locus, VNTR 1982 (5,7). Therefore, we believed that by 
identifying the conditions that provided good, reproducible 
discrimination, we would be able to define the optimal con-
ditions that would enable molecular epidemiologists to use 
VNTR 1982 and 3232. We addressed variability and repro-
ducibility for these 2 loci using MIRU 26 and ETR-B as 
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Figure 2. Agarose gel showing the stability of amplified fragments of 
variable number tandem repeat (VNTR) 3336 from 2 serial isolates 
isolated from 4 patients. Lane 1, patient A, isolate 1, isolated 2005 
Jun 20, 8 copies; lane 2, patient A, isolate 2, isolated 2005 Jul 11, 
8 copies; lane 3, patient B, isolate 1, isolated 2005 Jul 8, 9 copies; 
lane 4, patient B, isolate 2, isolated 2005 Aug 8, 9 copies; lane 5, 
patient C, isolate 1, isolated 2005 Nov 11, 7 copies; lane 6, patient 
C, isolate 2, isolated 2005 Nov 15, 7 copies; lane 7, patient D, 
isolate 1, isolated 2005 May 16, 6 copies; lane 8, patient D, isolate 
2, isolated 2005 May 25, 6 copies. 
Table 3. Discriminatory power of VNTR typing used in the study in establishing true minimum cluster size as marker of real 
transmission rate* 
Genotyping method 
No. distinct profiles 
(variety of types) 
No.
clusters 
Size of clusters, 
no. isolates 
Clustering
rate, % (n/N) 
Recent transmission 
rate, % ([n – c]/N)
No. unique 
isolates
MIRU15 (n = 2261) 1,271 235 2–53 54.2 44.0 1,036
MIRU15 + Spoligotyping 1,619 196 2–48 37.1 29.0 1,423
MIRU15 + VNTR7 1,888 158 2–35 22.2 17.0 1,730
*MIRU, mycobacterial interspersed repetitive unit; VNTR, variable number tandem repeats; n, no. clustered cases; N, total no. of strains; c, no. of clusters.
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controls that give stable comparable results in both agarose 
gel and capillary electrophoresis and have been used previ-
ously in a multilaboratory comparative study (7).
In all cases, identical data were produced for MIRU 26 
and ETR-B irrespective of the DNA polymerase used. Am-
plification of VNTR 1982 and 3232 varied with different 
DNA polymerases, particularly when expected fragments 
were long.
The differing performances of polymerases for am-
plifying different loci can be explained by their varying 
properties. BIOTAQ polymerase is a basic Taq that can 
be used for a wide range of templates, whereas Diamond 
polymerase has been modified by a point mutation at the 
active site of the enzyme, enabling it to read through re-
gions of secondary structure, microsatellites, and guanine 
cytosine–rich templates, such as those found in the M. tu-
berculosis genome. The QIAGEN polymerases are chemi-
cally modified polymerases with a high specificity similar 
to that of Diamond polymerase; thus they showed similar 
capabilities in amplifying VNTR 1982 and 3232. In addi-
tion, the buffer used with the QIAGEN polymerases is de-
signed to increase the specificity of primer binding, mak-
ing these polymerases suitable for dealing with complex 
genomic DNA.
Conditions that affect the denaturation of PCR prod-
ucts, and therefore their linearity before fragment sizing by 
electrophoresis, would be expected to influence apparent 
sizes of PCR fragments and copy number enumeration. We 
investigated the influence of DNA denaturation time and 
capillary separation temperature. As expected, we found 
that lowering the separation rate increased the discrimina-
tion of fragments >1,000 bp.
A marked difference was observed when the capillary 
temperature was decreased (method 3), which was indepen-
dent of the polymerase used and locus investigated and dem-
onstrated that separation conditions are critical for the cor-
rect interpretation of the VNTR typing results. In method 3, 
apparent fragment sizes were smaller and offset values were 
markedly larger, to the point that in some cases the calcu-
lated copy number was different from that expected.
Taking all the data together, we used BIOTAQ for 
amplifying MIRU and ETR loci, and Diamond polymerase 
for amplifying the extra 7 hypervariable VNTR loci, us-
ing the separation conditions detailed in method 1. We also 
demonstrated the reproducibility and stability of the extra 
7 VNTR loci by comparing 22 MIRU-VNTR profiles from 
serial isolates. The resulting profiles of serial isolates from 
the same patients were identical, indicating that the condi-
tions used for fragment amplification, detection, and analy-
sis were ideal for typing of these loci and that these loci 
could be used for routine genotyping.
Clustering rates seen by using 15 MIRU-ETR loci far 
exceeded those previously reported when IS6110 RFLP was 
used in a London population study (22,23). We concluded 
that 15-MIRU-ETR genotyping was insufficiently discrimi-
native and was producing so-called false clustering. This 
view was supported by the spoligotyping results in which 38 
(16%) of 235 isolates of 15 MIRU-ETR clusters contained 
isolates that belonged to >2 spoligo families (Table 3).
Applying all 22 loci gave the lowest clustering rate 
(22.2%) in MTBC strains obtained over 1 year from a sin-
gle metropolitan setting (London), a rate almost identical 
to the proportion established in previous studies conducted 
in London in 1993 and 1995–1997 (22,23) and similar to 
previously reported rates in population-based studies in 
low- to-middle TB incidence settings where RFLP and 
PCR-based genotyping methods were used (11,24–26). 
These findings suggest, from the public health viewpoint, 
that TB transmission in London has remained stable over 
the past decade. Our study provides strong evidence that 
PCR-based methods, especially VNTR-MIRU, can replace 
IS6110 RFLP typing for prospective analysis and that 12 
MIRU (27), and 15 MIRU-ETR loci panels alone are insuf-
ficiently discriminating for evaluation of TB transmission.
The recently proposed VNTR panel (3,5,7,11) pro-
vides similar degrees of discrimination (comparable to that 
achieved by IS6110 RFLP), although discrimination of in-
dividual VNTR loci is not equal for different MTBC genetic 
families (13). Inclusion of highly polymorphic VNTR loci 
effectively differentiates strains within highly conserved 
groups and is vital for prospective genotyping. Our study 
demonstrated that even in settings of low TB incidence and 
relatively low TB transmission rates, TB families, such as 
Beijing and CAS, remain more conserved than others, and 
hypervariable loci (e.g., VNTR 3232, 2163A, 4052) pro-
vide much higher discrimination than MIRU and ETR loci 
either alone or in combination.
Our current results agree with the preliminary results 
of our earlier studies about the applicability of hypervari-
able VNTR loci (VNTR 3232, VNTR 3336; VNTR 2163a, 
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Table 4. Allelic variants of additional hypervariable VNTR loci that cannot be resolved with the CEQ automated sequencer*† 
Locus
Maximum no. repeats suitable for 
automated analysis Fragment size, bp 
Proportion of strains with allelic variants beyond 
the automated system resolution, % 
3232 15 830 4.1
1982 9 880 11.9
2163A 11 876 10.8
3336 11 875 21.1
*Beckman Coulter, Fullerton, CA, USA. 
†VNTR, variable number tandem repeats. 
Analysis of M. tuberculosis Strains, UK
and VNTR1982, in particular) and recent reports (28–30) 
demonstrating their effectiveness for discrimination among 
Beijing strains. This agreement suggests that these loci are 
discriminating and reproducible, especially where Beijing 
strains are dominant (e.g., China, Russia, Baltic countries) 
(28) and should be included in standardized VNTR panels. 
They can be used successfully at multiple laboratories with 
consistent results, provided the conditions for proposed 
reaction and PCR fragment separation are adhered to and 
specific DNA polymerases are used.
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